CEMIP and cancer: The top four upregulated differentially expressed genes (DEGs), SAA2, UBE2C, CEMIP and ANXA8L1, have been associated with increased inflammation, cancer progression, metastatic potential and overall poor survival outcomes of various cancers including breast cancer [41,42,43,44].